Robert Yoder
Corporate Officer/Principal bij TREVENA, INC.
Vermogen: 73 083 $ op 31-03-2024
Profiel
Robert T.
Yoder is currently the Chief Business Officer & Senior Vice President at Trevena, Inc. Prior to his current position, he worked as the Head of Information Technology at Orexigen Therapeutics, Inc. from 2015 to 2018.
Mr. Yoder holds an MBA from Emory University and an undergraduate degree from Dickinson College.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
TREVENA, INC.
0.87% | 14-12-2023 | 158 877 ( 0.87% ) | 73 083 $ | 31-03-2024 |
Actieve functies van Robert Yoder
| Bedrijven | Functie | Begin |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10-12-2018 |
Eerdere bekende functies van Robert Yoder
| Bedrijven | Functie | Einde |
|---|---|---|
| OREXIGEN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-06-2018 |
Opleiding van Robert Yoder
| Emory University | Masters Business Admin |
| Dickinson College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orexigen Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its primary activities include recruiting personnel, conducting research and development, including clinical trials, raising capital, and preparing for the marketing and commercialization of its product, contrave. The company was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA. | Health Technology |
